Medtronic (MDT) Q3 2022 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2021.
Stay updated with breaking news from Brain Modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MDT earnings call for the period ending December 31, 2021.
MDT earnings call for the period ending April 30, 2021.
Vice President, Head of Investor Relations Good morning and welcome to Medtronic's Fiscal Year 2021 Third Quarter Earnings Video Webcast. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. Before we start the prepared remarks, I'm going to share with you a few details to keep in mind about today's webcast. Joining me today are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our third quarter, which ended on January 29, 2021. After our prepar...
BPH Energy Limited (ASX:BPH) Cortical Dynamics Patent and Advisory Panel Appoint Update Cortical Dynamics Patent and Advisory Panel Appoint UpdatePerth, Jan 22, 2021 AEST (ABN Newswire) - BPH Energy Ltd ( ASX:BPH) investee company Cortical Dynamics Ltd ("Cortical") is pleased to announce the issuance of European Patent Number 2088924 "Neurodiagnostic Monitoring and display System" in Belgium, France, Germany and United Kingdom. Cortical has developed an extensive patent portfolio encapsulating the BARM, providing critical patent protection across a number of key brain monitoring mark...
Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients Medtronic unveils adaptive deep brain stimulation trial in Parkinson's patients 15 January 2021 | News The randomised study will take place across 12 study sites at leading movement disorders research centers in the US, Europe, and Canada Source: medtronic.com Medtronic plc, the global leader in medical technology, announced the first enrolment in ADAPT-PD (Adaptive DBS Algorithm for Personalised Therapy in Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain...